Cancer clinical trials in the region Pays de la Loire
174 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 2
Breast cancer
#NCT04985266
HER2 Negative
HR Positive
Localized
Surgery
Chemotherapy
Hormone therapy
Targeted therapy
Institut de Cancérologie et d’Hématologie Universitaire de Saint-Étienne (CHU Saint-Étienne) (Saint-Priest-en-Jarez), Institut Bergonié (Bordeaux), Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Centre Hospitalier Annecy Genevois (Epagny Metz-Tessy), Centre Hospitalier de Blois (Blois) (and 16 more...)
Fiducie de la Fondation Royal Marsden NHS
Phase 2
Colon cancer
Rectal cancer
#NCT04730544
Locally Advanced
Metastatic
MSI/dMMR
MSS
Immunotherapy
Bispecific T-cell engager antibodies
Immunotherapy
Bispecific T-cell engager antibodies
Institut Sainte Catherine (Avignon), CHU - Haut-lévêque - Bordeaux (Pessac), Centre Hospitalier Universitaire de Besançon (Besançon), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Centre Hospitalier Universitaire de Lille (Lille) (and 9 more...)
GERCOR - Groupe Coopératif Multidisciplinaire d'Oncologie
Phase 2
Lymphoma
#NCT04446962
B cell lymphoma
Primary cerebral lymphoma
Systemic Treatment-Naive
None
Centre Hospitalier Universitaire de Besançon (Besançon), Centre Hospitalier Universitaire de Clermont Ferrand (Clermont-Ferrand), Centre Antoine Lacassagne (Nice), Centre Henri Becquerel (Rouen ), Centre Hospitalier de Colmar (Colmar) (and 17 more...)
Institut Curie
Phase 2
Breast cancer
#NCT04143711
HER2 Low
HER2 Positive
Locally Advanced
Metastatic
Targeted therapy
Antibody Drug Conjugates (ADC)
Systemic Treatment-Naive
Groupe Hospitalier Saint André (Bordeaux), Centre Oscar Lambret (Lille), Centre Léon Bérard (Lyon), Institut Paoli-Calmettes (Marseille), Institut Curie - Paris (Paris) (and 2 more...)
Dragonfly Therapeutics
Phase 2
Breast cancer
#NCT04143711
HER2 Negative
HR Positive
Locally Advanced
Metastatic
Systemic Treatment-Naive
Groupe Hospitalier Saint André (Bordeaux), Centre Oscar Lambret (Lille), Centre Léon Bérard (Lyon), Institut Paoli-Calmettes (Marseille), Institut Curie - Paris (Paris) (and 2 more...)
Dragonfly Therapeutics
Phase 2
Lung cancer
#NCT04143711
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
HER2
Immunotherapy
Chemotherapy
Systemic Treatment-Naive
Groupe Hospitalier Saint André (Bordeaux), Centre Oscar Lambret (Lille), Centre Léon Bérard (Lyon), Institut Paoli-Calmettes (Marseille), Institut Curie - Paris (Paris) (and 2 more...)
Dragonfly Therapeutics
Phase 2
Lymphoma
#NCT03888105
B cell lymphoma
Large B cell lymphoma
Primary mediastinal lymphoma
Mantel cell lymphoma
Follicular lymphoma
Marginal zone lymphoma
MALT lymphoma
Lymphocytic lymphoma
Indolent transformed lymphoma
None
2
3 or more
Systemic Treatment-Naive
Car-T
Bispecific T-cell engager antibodies
Allogeneic stem cell transplant
CHU Caen Normandie (Caen), Hôpital Saint Louis AP-HP (Paris), CHU - Haut-lévêque - Bordeaux (Pessac), Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers), Hôpital Henri-Mondor AP-HP (Créteil) (and 4 more...)
Regeneron Pharmaceuticals
Phase 2
Prostate cancer
#NCT03438552
Adenocarcinoma
Biochemical recurrence
Radiotherapy
Systemic Treatment-Naive
Immunotherapy
Chemotherapy
Car-T
Bispecific T-cell engager antibodies
Antibody Drug Conjugates (ADC)
Centre François Baclesse (Caen ), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre Jean Perrin (Clermont Ferrand ), Institut du cancer de Montpellier (Montpellier), Centre Oscar Lambret (Lille) (and 6 more...)
UNICANCER
Phase 2
Kidney cancer
#NCT03175224
Locally Advanced
Metastatic
Other mutation
Centre Hospitalier Universitaire de Lille (Lille), Centre Léon Bérard (Lyon), CHU de Rennes - Hôpital Pontchaillou (Rennes), Gustave Roussy (Villejuif), Hôpital de la Timone AP-HM (Marseille) (and 2 more...)
Apollomics
Phase 2
Lung cancer
#NCT03175224
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
MET
Targeted therapy
BRAF
ALK
RET
ROS-1
NTRK-1/2/3
KRAS G12C
KRAS non G12C
Systemic Treatment-Naive
Centre Hospitalier Universitaire de Lille (Lille), Centre Léon Bérard (Lyon), CHU de Rennes - Hôpital Pontchaillou (Rennes), Gustave Roussy (Villejuif), Hôpital de la Timone AP-HM (Marseille) (and 2 more...)
Apollomics